Figures & data
Figure 1. Effect of icariin on cell viability in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin (10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, cell viability was analyzed using MTT assay. Mean ± SD for 10 samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.
![Figure 1. Effect of icariin on cell viability in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin (10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, cell viability was analyzed using MTT assay. Mean ± SD for 10 samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.](/cms/asset/7ec2c14d-2bc3-48b9-9573-9e9468a7a2f1/iphb_a_1281968_f0001_b.jpg)
Figure 2. Effect of icariin on HIF-1α levels in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin (10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, HIF-1α levels in cell supernatant fluid were analyzed using ELISA assay. Mean ± SD for six samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.
![Figure 2. Effect of icariin on HIF-1α levels in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin (10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, HIF-1α levels in cell supernatant fluid were analyzed using ELISA assay. Mean ± SD for six samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.](/cms/asset/2bef1351-d9e4-496e-a255-ff6d71431bde/iphb_a_1281968_f0002_b.jpg)
Figure 3. Effect of icariin on HSP-60 levels in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin (10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, HSP60 levels in cell supernatant fluid were analyzed using ELISA assay. Mean ± SD for six samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.
![Figure 3. Effect of icariin on HSP-60 levels in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin (10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, HSP60 levels in cell supernatant fluid were analyzed using ELISA assay. Mean ± SD for six samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.](/cms/asset/4795a87c-6388-491a-b0bf-95a107e60acf/iphb_a_1281968_f0003_b.jpg)
Figure 4. Effect of icariin on HSP-70 levels in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin(10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, HSP70 levels in cell supernatant fluid were analyzed using ELISA assay. Mean ± SD for six samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.
![Figure 4. Effect of icariin on HSP-70 levels in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin(10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, HSP70 levels in cell supernatant fluid were analyzed using ELISA assay. Mean ± SD for six samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.](/cms/asset/a2fc55ea-f244-4087-8712-160d2144757e/iphb_a_1281968_f0004_b.jpg)
Figure 5. Effect of icariin on NSE levels in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin(10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, NSE levels in cell supernatant fluid was analyzed using ELISA assay. Mean ± SD for six samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.
![Figure 5. Effect of icariin on NSE levels in OGD-treated PC12 cells. Model control cells were treated with 2 h OGD. The treated cells were incubated with icariin(10−7, 10−6 or 10−5 mol/L) or nimodipine (10 μmol/L) 1 h before OGD and 2 h throughout OGD. Normal control cells were incubated in a regular cell culture incubator under normoxic conditions. After these treatments, NSE levels in cell supernatant fluid was analyzed using ELISA assay. Mean ± SD for six samples. ##p < 0.01 vs normal control group. **p < 0.01 vs model control group.](/cms/asset/d8ba318e-d557-47b2-8b8d-26520e8326cb/iphb_a_1281968_f0005_b.jpg)